of imipramine HCl should not be exceeded in childhood. ECG changes of unknown tofranil 25mg have been reported in pediatric patients tofranil 25mg doses twice this amount.Extreme caution should be used when this drug is given to: patients with cardiovascular disease tofranil 25mg of tofranil 25mg possibility of conduction.

to instituting a drug free period following an adequate therapeutic trial with a favorable response. Dosage should be tapered tofranil 25mg gradually rather than abruptly discontinued; this may reduce the tendency to relapse. Children who relapse when the drug is discontinued do not tofranil 25mg respond tofranil 25mg a subsequent course of treatment.A dose of 2.5 tofranil 25mg should tofranil 25mg be exceeded. ECG changes of unknown significance have been reported in pediatric tofranil 25mg with doses twice this amount.The safety and effectiveness of Tofranil tofranil 25mg temporary tofranil 25mg therapy for nocturnal enuresis tofranil 25mg children less tofranil 25mg tofranil 25mg years of age has not tofranil 25mg established.HOW SUPPLIEDTablets 10 mg – triangular, biconvex, coral-reddish brown, tofranil 25mg tofranil 25mg imprinted with M on one side and “10” on the other side in black.Bottles of 30........................NDC 0406-9920-03Bottles of 100 .....................NDC 0406-9920-01Tablets 25 mg – round, tofranil 25mg coral-reddish brown, sugar-coated tablet, imprinted with M on one side and “25” on the other tofranil 25mg the.

before optimal therapeutic effects are tofranil 25mg Enuresis – May be useful as temporary adjunctive.